Literature DB >> 24126108

The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI).

Joseph L Mills1, Michael S Conte2, David G Armstrong3, Frank B Pomposelli4, Andres Schanzer5, Anton N Sidawy6, George Andros7.   

Abstract

Critical limb ischemia, first defined in 1982, was intended to delineate a subgroup of patients with a threatened lower extremity primarily because of chronic ischemia. It was the intent of the original authors that patients with diabetes be excluded or analyzed separately. The Fontaine and Rutherford Systems have been used to classify risk of amputation and likelihood of benefit from revascularization by subcategorizing patients into two groups: ischemic rest pain and tissue loss. Due to demographic shifts over the last 40 years, especially a dramatic rise in the incidence of diabetes mellitus and rapidly expanding techniques of revascularization, it has become increasingly difficult to perform meaningful outcomes analysis for patients with threatened limbs using these existing classification systems. Particularly in patients with diabetes, limb threat is part of a broad disease spectrum. Perfusion is only one determinant of outcome; wound extent and the presence and severity of infection also greatly impact the threat to a limb. Therefore, the Society for Vascular Surgery Lower Extremity Guidelines Committee undertook the task of creating a new classification of the threatened lower extremity that reflects these important considerations. We term this new framework, the Society for Vascular Surgery Lower Extremity Threatened Limb Classification System. Risk stratification is based on three major factors that impact amputation risk and clinical management: Wound, Ischemia, and foot Infection (WIfI). The implementation of this classification system is intended to permit more meaningful analysis of outcomes for various forms of therapy in this challenging, but heterogeneous population.
Copyright © 2014 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24126108     DOI: 10.1016/j.jvs.2013.08.003

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  207 in total

1.  An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC Steering Comittee(.).

Authors:  Michael R Jaff; Christopher J White; William R Hiatt; Gerry R Fowkes; John Dormandy; Mahmood Razavi; Jim Reekers; Lars Norgren
Journal:  Ann Vasc Dis       Date:  2015-10-23

2.  Alterations in gait parameters with peripheral artery disease: The importance of pre-frailty as a confounding variable.

Authors:  Nima Toosizadeh; Hannah Stocker; Rebecca Thiede; Jane Mohler; Joseph L Mills; Bijan Najafi
Journal:  Vasc Med       Date:  2016-09-15       Impact factor: 3.239

3.  Ulcer-free survival days and ulcer healing in patients with diabetic foot ulcers: A prospective cohort study.

Authors:  Afram Akturk; Jaap J van Netten; Rene Scheer; Marloes Vermeer; Jeff G van Baal
Journal:  Int Wound J       Date:  2019-08-19       Impact factor: 3.315

4.  Micronutrient Status in Diabetic Patients with Foot Ulcers.

Authors:  Guilherme Pena; Beatrice Kuang; Prue Cowled; Stuart Howell; Joseph Dawson; Ross Philpot; Robert Fitridge
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-12-06       Impact factor: 4.730

Review 5.  Clinical Assessment of Peripheral Arterial Disease in the Office: What Do the Guidelines Say?

Authors:  Srini Tummala; Derek Scherbel
Journal:  Semin Intervent Radiol       Date:  2019-02-05       Impact factor: 1.513

6.  Predictors of Unplanned Reoperation for Ovarian Cancer Patients From the National Surgical Quality Improvement Program Database.

Authors:  Michael D Toboni; Haller J Smith; Sejong Bae; J Michael Straughn; Charles A Leath
Journal:  Int J Gynecol Cancer       Date:  2018-09       Impact factor: 3.437

7.  The relationship between medical expenses and the severity of peripheral arterial disease in Japan.

Authors:  Akihiko Seo; Kota Yamamoto; Atsushi Akai; Daisuke Akagi; Toshio Takayama; Katsuyuki Hoshina
Journal:  Heart Vessels       Date:  2018-02-02       Impact factor: 2.037

8.  Elevated serum phosphate levels are associated with decreased amputation-free survival after interventions for critical limb ischemia.

Authors:  Sara L Zettervall; Peter A Soden; Klaas H J Ultee; Crystal Seldon; Jinhee Oh; Kevin McGann; Marc L Schermerhorn; Raul J Guzman
Journal:  J Vasc Surg       Date:  2016-09-22       Impact factor: 4.268

9.  The silent overall burden of foot disease in a representative hospitalised population.

Authors:  Peter A Lazzarini; Sheree E Hurn; Suzanne S Kuys; Maarten C Kamp; Vanessa Ng; Courtney Thomas; Scott Jen; Jude Wills; Ewan M Kinnear; Michael C d'Emden; Lloyd F Reed
Journal:  Int Wound J       Date:  2016-10-03       Impact factor: 3.315

10.  Regional variation in patient selection and treatment for lower extremity vascular disease in the Vascular Quality Initiative.

Authors:  Peter A Soden; Sara L Zettervall; Thomas Curran; Ageliki G Vouyouka; Philip P Goodney; Joseph L Mills; John W Hallett; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2016-09-28       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.